Bisphosphonate use and femoral fractures in older women [4]

JAMA

Volumn 305, Issue 20, 2011, Pages 2068-2069

  Pfister, Alfred K ^a   Trotter, Christopher C ^a  

^a West Virginia University School of Medicine Charleston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; OPIATE; PROTON PUMP INHIBITOR;

AGE; CONGESTIVE HEART FAILURE; DEMENTIA; DRUG USE; FALLING; FEMUR FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; GENDER; HUMAN; LETTER; LONG TERM CARE; MEDICAL HISTORY; PRIORITY JOURNAL; RISK; SHORT COURSE THERAPY; TREATMENT DURATION; AGED; DRUG ADMINISTRATION; FEMALE; HIP FRACTURE; NOTE; REPRODUCIBILITY; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL FRACTURES; HIP FRACTURES; HUMANS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 79957509775     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.674     Document Type: Letter

References (2)

1. Park-Wyllie LY, Mamdani MM, Juurlink DN, et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011;305(8):783-789.
2. Trotter CC, Pfister AK, Whited BA, Goldberg TH, Artz SA. A controversy: linking atypical femoral fractures to bisphosphonate therapy. W V Med J. 2011;107(2):8-13.